Haifa ghandour
US Diagnostics Lead Alexion Pharma UK
Haifa Ghandour, PhD, is US Diagnostics Lead, US Business Diagnostics at Alexion, AstraZeneca Rare Disease, a role held since April 2026 after joining as Associate Director, Diagnostics Strategy & Development. Previously, Haifa was Associate Director, Companion Diagnostics, Development & Validation at Foundation Medicine, and held roles at Aldatu Biosciences, Bio-Rad Laboratories and GnuBIO.
Seminars
Friday 19th March 2027
Diagnostics Landscape in Rare Diseases: Challenges, Solutions & Actions to Improve Patients’ Journey
4:10 pm
- An overview of the rare disease landscape and key barriers to timely and accurate diagnosis
- Insights into development and adoption of diagnostics approaches, the influence on patient outcomes and healthcare delivery
- Fostering cross-sector collaboration to harmonize access and diagnostics standards to improve guidelines and patient care
